Stage IB Breast Cancer Completed Phase 1 Trials for Rasdegafusp alfa (DB15185)

IndicationStatusPhase
DBCOND0029218 (Stage IB Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01522820Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsTreatment